The treatment will be available under the Cancer Drugs Fund
Physicians are again discussing hospice care with patients.
This response rate is more than double that in the phase 2 HER2CLIMB study.
Rapid, durable responses seen especially in high-grade gliomas.
The treatment is available through the Cancer Drugs Fund
Adjusting for site and stage eliminate the link between chemotherapy and stroke.
The test identifies tissue of origin too.
Cancer patients may be at high risk for complications, especially those with lymphopenia, neutropenia.
Findings from Wuhan, China, suggest aggressive measures to curtail frequency of hospital visits.
Findings from a prospective study of UK participants.
High-dose products are to be used only when other options, including lower doses, have failed.
Central nervous system tumours like glioblastoma present unique challenges and opportunities for immuno-oncology.
Patient clinical and radiographic characteristics should be taken into account to prescribe the best treatment options.
A single centre retrospective study shows durable effects with pembrolizumab.
Strategies to better tailor effective treatments are needed.
The oral tyrosine receptor kinase inhibitor, larotrectinib, is the first treatment in the EU to receive a tumour-agnostic indication.
Bisphosphonates, denosumab are preferred.
